Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Life sciences is among the most ...

The NVIDIA-Powered AI Drug Discovery Ecosystem Across the globe, innovators are building the future of AI for drug discovery ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

A team at Japan's National Institutes for Quantum Science and Technology (QST) has published a field-defining Perspective ...

When we think of artificial intelligence (AI), data science and the potential real-world impact of these rapidly developing fields, we tend to look to the future—particularly when it comes to health.

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

New Jersey is emerging as a national leader in AI-driven life sciences, transforming health care, drug discovery and ...

Fujifilm Biotechnologies is completing the first phase of a $3.2 billion end-to-end biomanufacturing facility in Holly Springs, NC, set to open on September 24. Fujifilm Biotechnologies, a contract ...

On the 12th (local time), the ‘JP Morgan Healthcare Conference’ opened in San Francisco, U.S. The biggest topic at this ...

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...